NEW YORK – Merck & Co. has announced the Alexa Diabetes Challenge for Alexa voice-enabled solutions for those with Type 2 diabetes. Innovators are invited to submit concepts that use Amazon Alexa capabilities and the ecosystem of supporting cloud technologies help with the self-management of the disease. Up to five finalists will be chosen by a panel of judges to receive $25,000 each and 10,000 Amazon Web Services credits to advance to the Virtual Accelerator, during which they will receive expert mentorship as they develop their concepts into solutions. A $125,000 grand prize winner will be chosen at a Demo Day.
You are here: / / Voice-enabled innovations sought for diabetes self-care